(Q43256632)

17 November 2017

title

Regulation of arteriolar density in adult myocardium during low thyroid conditions (English)

1 reference

17 November 2017

Yingheng Liu

1

1 reference

17 November 2017

Benjamin A Sherer

series ordinal

2

1 reference

17 November 2017

Rebecca A Redetzke

series ordinal

3

1 reference

17 November 2017

A Martin Gerdes

series ordinal

4

1 reference

17 November 2017

publication date

20 October 2009

1 reference

17 November 2017

published in

Vascular Pharmacology

1 reference

17 November 2017

volume

52

1 reference

17 November 2017

issue

3-4

1 reference

17 November 2017

page(s)

146-150

1 reference

Myocardial characteristics of thyroxine stimulated hypertrophy. A structural and functional study

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Thyroid hormone treatment after coronary-artery bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Decreased arteriolar density in endothelial nitric oxide synthase knockout mice is due to hypertension, not to the constitutive defect in endothelial nitric oxide synthase enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Acute effects of triiodothyronine on arterial smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Acute effects of thyroid hormone on vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Coordinated capillary and myocardial growth in response to thyroxine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

Early coronary angiogenesis in response to thyroxine: growth characteristics and upregulation of basic fibroblast growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

A thyroid hormone analog stimulates angiogenesis in the post-infarcted rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

T4-induced cardiac hypertrophy and the perfused and total microvasculature of the heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2009.10.003

10.1016/J.VPH.2009.10.003

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference